MedPath

Outcome of patients treated with chemotherapy and Radiation in Cervical Cancer.

Not Applicable
Conditions
Health Condition 1: null- Cancer of Cervix
Registration Number
CTRI/2014/06/004699
Lead Sponsor
A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

Histologically confirmed FIGO stage Ib2-IVa squamous, adeno or adenosquamous carcinoma of the cervix.

Received Neo-adjuvant chemotherapy (NACT) followed by Chemo-radiotherapy (CRT) or Radiotherapy (RT).

Minimum follow-up of 2 years after completion of Chemo-radiotherapy (CRT) / Radiotherapy (RT).

Exclusion Criteria

Incomplete definitive treatment.

Not received Chemo-radiotherapy (CRT) / Radiotherapy (RT).

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate Neoadjuvant chemortherapy(NACT)followed by radical chemoradiotherapy(CRT) or radiotherapy(RT) in locally advanced cervical cancer in terms of Response rates, Compliance of NACT followed by Radical Chemoradiotherapy/Radiotherapy & Disease free & overall survivals & factors affecting the outcome.Timepoint: 2 Years
Secondary Outcome Measures
NameTimeMethod
To evaluate Neoadjuvant chemortherapy(NACT)followed by radical chemoradiotherapy(CRT) or radiotherapy(RT) in locally advanced cervical cancer in terms of Response rates, Compliance of NACT followed by Radical Chemoradiotherapy/Radiotherapy & Disease free & overall survivals & factors affecting the outcome.Timepoint: 2 Years
© Copyright 2025. All Rights Reserved by MedPath